Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals to Consider Q2 FY27 Unaudited Results on Oct 29, 2026
BOARD
● No Immediate Change
LOW RISK
📅 Filed on BSE: 22 Oct 2026, 02:47 PM IST · BSE ID: db8d07ea-1d26-44b9-8e2e-0f769d4ea635
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet to approve the latest financial performance reports for the July-September quarter and the first half of the fiscal year.
🤖 AI Summary
- Lincoln Pharmaceuticals board meeting scheduled for October 29, 2026.
- Agenda includes approval of Q2 and H1 FY27 un-audited financial results.
- Both standalone and consolidated results will be presented to the board.
- Trading window closed from October 01, 2026, reopening 48 hours post-results.
🏢 How This Affects the Company
The un-audited financial results will provide an update on the company's revenue and profitability for the specified periods, influencing investor sentiment and future strategic decisions.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Shareholders will be informed of the financial results once they are released.
👤
Who Is Affected
All shareholders of Lincoln Pharmaceuticals will be affected by the disclosure of the un-audited financial results.
🔍
Management Signal
The scheduling of the board meeting signals management's commitment to timely financial reporting and regulatory compliance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Board meeting on October 29, 2026, for results approval.
Disclosure of Q2 and H1 FY27 un-audited financial results.
Reopening of trading window 48 hours after results become public.
LOW RISK
This filing is a routine announcement of a board meeting for financial result approval.
💡 Investor Takeaway
Lincoln Pharmaceuticals will announce its un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, on October 29, 2026.
❓ Frequently Asked Questions
When will Lincoln Pharmaceuticals announce its Q2 and H1 FY27 financial results?
Lincoln Pharmaceuticals will announce its un-audited financial results for the quarter and half-year ended September 30, 2026, on October 29, 2026, following Board approval.
What is the purpose of the Board Meeting on October 29, 2026?
The Board Meeting on October 29, 2026, is scheduled to consider and approve the un-audited financial results (standalone and consolidated) for the quarter and half-year ended September 30, 2026.
When is the trading window closed for Lincoln Pharmaceuticals?
The trading window for Lincoln Pharmaceuticals is closed from October 01, 2026, and will reopen 48 hours after the financial results become generally available.
Questions based on this BSE filing only. For information purposes.